The liver of myeloid-specific METTL3 knockout mice showed lower levels of lipid accumulation and monocyte infiltration, as well as low NAFLD activity inflammation scores (74). This evidence concerns the gene METTL3 and metabolic dysfunction-associated steatotic liver disease.